{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:05:37Z","timestamp":1793822737123,"version":"4.6.1"},"reference-count":34,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,5,15]]},"DOI":"10.2169\/internalmedicine.9668-17","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T22:17:34Z","timestamp":1515622654000},"page":"1445-1453","source":"Crossref","is-referenced-by-count":8,"title":["Synchronous Occurrence of Mycosis Fungoides, Diffuse Large B Cell Lymphoma and Acute Myeloid Leukemia"],"prefix":"10.2169","volume":"57","author":[{"given":"Junichi","family":"Miyatake","sequence":"first","affiliation":[{"name":"Department of Hematology, Sakai Hospital Kindai University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentarou","family":"Serizawa","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyoshi","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JL","family":"Espinoza","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Tatsumi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ashida","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Matsumura","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Girardi M, Heald PW, Wilson LD. The pathogenesis of mycosis fungoides. N Engl J Med 350: 1978-1988, 2004.","DOI":"10.1056\/NEJMra032810"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Oluwole OO, Zic JA, Douds JJ, Ann Thompson M, Greer JP. Cutaneous manifestations and management of hematologic neoplasms. Semin Oncol 43: 370-383, 2016.","DOI":"10.1053\/j.seminoncol.2016.02.021"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Chang D, Zerbini MC, Sotto MN, Siqueira SA, Sanches JA. Evaluation of the 2008 world health organization classification for non-mycosis fungoides, non- S\u00e9zary syndrome T\/NK-cell lymphomas with primary cutaneous involvement. J Cutan Pathol 2015 (Epub ahead of print).","DOI":"10.1111\/cup.12599"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Amber KT, Bloom R, Nouri K. Second primary malignancies in CTCL patients from 1992 to 2011: A seer-based, population-based study evaluating time from ctcl diagnosis, age, sex, stage, and CD30<sup>+<\/sup> subtype. Am J Clin Dermatol 17: 71-77, 2016.","DOI":"10.1007\/s40257-015-0155-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Brownell I, Etzel CJ, Yang DJ, Taylor SH, Duvic M. Increased malignancy risk in the cutaneous T-cell lymphoma patient population. Clin Lymphoma Myeloma 8: 100-105, 2008.","DOI":"10.3816\/CLM.2008.n.011"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Jiang M, Bennani NN, Feldman AL. Lymphoma classification update: B-cell non-Hodgkin lymphomas. Expert Rev Hematol 10: 405-415, 2017.","DOI":"10.1080\/17474086.2017.1318053"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lossos IS, Gascoyne RD. Transformation of follicular lymphoma. Best Pract Res Clin Haematol 24: 147-163, 2011.","DOI":"10.1016\/j.beha.2011.02.006"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Espinoza JL, Elbadry MI, Taniwaki M, et al. The simultaneous inhibition of the mTOR and mapk pathways with gnetin-c induces apoptosis in acute myeloid leukemia. Cancer Lett 400: 127-136, 2017.","DOI":"10.1016\/j.canlet.2017.04.027"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Stieglitz E, Taylor-Weiner AN, Chang TY, et al. The genomic landscape of juvenile myelomonocytic leukemia. Nat Genet 47: 1326-1333, 2015.","DOI":"10.1038\/ng.3400"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Cerroni L. Past, present and future of cutaneous lymphomas. Semin Diagn Pathol 34: 3-14, 2017.","DOI":"10.1053\/j.semdp.2016.11.001"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Agar NS, Wedgeworth E, Crichton S, et al. Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: Validation of the revised international society for cutaneous lymphomas\/european organisation for research and treatment of cancer staging proposal. J Clin Oncol 28: 4730-4739, 2010.","DOI":"10.1200\/JCO.2009.27.7665"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Barzilai A, Trau H, David M, et al. Mycosis fungoides associated with B-cell malignancies. Br J Dermatol 155: 379-386, 2006.","DOI":"10.1111\/j.1365-2133.2006.07346.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Chan BC, Stefanato CM, Moonim M, et al. Diffuse large B-cell lymphoma developing in erythrodermic cutaneous T-cell lymphoma: A case series. Br J Dermatol 177: e138-e140, 2017.","DOI":"10.1111\/bjd.15460"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Bagot M. New targeted treatments for cutaneous T-cell lymphomas. Indian J Dermatol 62: 142-145, 2017.","DOI":"10.4103\/ijd.IJD_73_17"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wilcox RA. Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol 91: 151-165, 2016.","DOI":"10.1002\/ajh.24233"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Rasheed H, Hegazy RA, Gawdat HI, et al. Serum vitamin D and vitamin D receptor gene polymorphism in mycosis fungoides patients: A case control study. PLoS One 11: e0158014, 2016.","DOI":"10.1371\/journal.pone.0158014"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. McGirt LY, Jia P, Baerenwald DA, et al. Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides. Blood 126: 508-519, 2015.","DOI":"10.1182\/blood-2014-11-611194"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Smedby KE, Hjalgrim H, Melbye M, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 97: 199-209, 2005.","DOI":"10.1093\/jnci\/dji022"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Chang ET, Canchola AJ, Cockburn M, et al. Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the california teachers study. Blood 118: 1591-1599, 2011.","DOI":"10.1182\/blood-2011-02-336065"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Mohr SB, Garland CF, Gorham ED, Grant WB, Garland FC. Ultraviolet B and incidence rates of leukemia worldwide. Am J Prev Med 41: 68-74, 2011.","DOI":"10.1016\/j.amepre.2011.04.003"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Uehara M, Takahashi K, Hoshuyama T, Pan G, Feng Y. Geographical correlation between ambient UVB level and mortality risk of leukemia in Japan. Environ Res 92: 78-84, 2003.","DOI":"10.1016\/S0013-9351(03)00034-3"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kwong YL, Au WY, Ng MH, Chan LC, Au TS. Acute myeloid leukemia following psoralen with ultraviolet a therapy: a fluorescence in situ hybridization study. Cancer Genet Cytogenet 99: 11-13, 1997.","DOI":"10.1016\/S0165-4608(96)00429-3"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Wolach O, Stone RM. Mixed-phenotype acute leukemia: current challenges in diagnosis and therapy. Curr Opin Hematol 24: 139-145, 2017.","DOI":"10.1097\/MOH.0000000000000322"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Lindsley RC, Mar BG, Mazzola E, et al. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood 125: 1367-1376, 2015.","DOI":"10.1182\/blood-2014-11-610543"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kubuki Y, Yamaji T, Hidaka T, et al. Tet2 mutation in diffuse large b-cell lymphoma. J Clin Exp Hematop 56: 145-149, 2017.","DOI":"10.3960\/jslrt.56.145"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Lemonnier F, Couronn\u00e9 L, Parrens M, et al. Recurrent <i>TET2<\/i> mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood 120: 1466-1469, 2012.","DOI":"10.1182\/blood-2012-02-408542"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Asmar F, Punj V, Christensen J, et al. Genome-wide profiling identifies a DNA methylation signature that associates with <i>TET2<\/i> mutations in diffuse large B-cell lymphoma. Haematologica 98: 1912-1920, 2013.","DOI":"10.3324\/haematol.2013.088740"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Fernandez-Mercado M, Yip BH, Pellagatti A, et al. Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics. PLoS One 7: e42334, 2012.","DOI":"10.1371\/journal.pone.0042334"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Buffet PA, Safeukui I, Deplaine G, et al. The pathogenesis of plasmodium falciparum malaria in humans: insights from splenic physiology. Blood 117: 381-392, 2011.","DOI":"10.1182\/blood-2010-04-202911"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Kristinsson SY, Gridley G, Hoover RN, Check D, Landgren O. Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up. Haematologica 99: 392-398, 2014.","DOI":"10.3324\/haematol.2013.092460"},{"key":"31","unstructured":"31. Aksoy S, Arslan C, Harputluoglu H, Dizdar O, Altundag K. Malignancies after rituximab treatment: just coincidence or more? J BUON 16: 112-115, 2011."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Fleury I, Chevret S, Pfreundschuh M, et al. Rituximab and risk of second primary malignancies in patients with non-Hodgkin lymphoma: a systematic review and meta-analysis. Ann Oncol 27: 390-397, 2016.","DOI":"10.1093\/annonc\/mdv616"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Krejsgaard T, Odum N, Geisler C, et al. Regulatory T cells and immunodeficiency in mycosis fungoides and S\u00e9zary syndrome. Leukemia 26: 424-432, 2012.","DOI":"10.1038\/leu.2011.237"},{"key":"34","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1182\/blood-2014-09-600924","volume":"125","author":"M Duvic","year":"2015","unstructured":"34. Duvic M, Pinter-Brown LC, Foss FM, et al. Phase 1\/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma. Blood 125: 1883-1889, 2015.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/10\/57_9668-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T06:51:37Z","timestamp":1570603897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/10\/57_9668-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,15]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9668-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,15]]}}}